Evidence & regulatory context
- Mechanism
- CHEMBL NOT QUERIED: this is a bespoke synthetic polymer DEVICE, a superporous cholesterol-modified pHEMA hydrogel scaffold defined by its copolymerisation recipe and pore architecture rather than by a single molecular entity, so no ChEMBL drug record can exist.
- Target
- Not recorded
- Injury models
- Spinal cord injury
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatSpinal cord injuryHemisection / partialWistarMaleImplanted into the spinal cord to bridge the hemisection cavityImplanted at the time of acute hemisection injury, with histological assessment…
Model: Acute spinal cord hemisection creating a cavity bridged by an implanted hydrogel; complemented by in vitro culture of rat mesenchymal stem cells on the scaffolds
The hydrogels supported in vitro adhesion and proliferation of rat mesenchymal stem cells, and at 4 weeks after implantation showed good incorporation into surrounding tissue with progressive connective tissue infiltration and ingrowth of neurofilaments, Schwann cells and blood vessels into the por…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.